TP53 and lung carcinoma: Since mutant p53 stabilization is crucial for the gain-of-function activity, lung cancer cell lines (HCC827 and H1435) with different mutant p53 status (V218del and C141W, respectively) were treated with simvastatin to determine whether simvastatin enhances the mutant p53 degradation.